Finne P - Search Results

1

Lead-time in the European Randomised Study of Screening for Prostate Cancer.

Finne P, Fallah M, Hakama M, Ciatto S, Hugosson J, de Koning H, Moss S, Nelen V, Auvinen A. Finne P, et al. Eur J Cancer. 2010 Nov;46(17):3102-8. doi: 10.1016/j.ejca.2010.09.034. Eur J Cancer. 2010. PMID: 21047593 Clinical Trial.

2

Prostate-specific antigen.

Stenman UH, Leinonen J, Zhang WM, Finne P. Stenman UH, et al. Among authors: finne p. Semin Cancer Biol. 1999 Apr;9(2):83-93. doi: 10.1006/scbi.1998.0086. Semin Cancer Biol. 1999. PMID: 10202130 Review.

3

Determination of prostate-specific antigen complexed to alpha(2)-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer.

Zhang WM, Finne P, Leinonen J, Salo J, Stenman UH. Zhang WM, et al. Among authors: finne p. Urology. 2000 Aug 1;56(2):267-72. doi: 10.1016/s0090-4295(00)00609-9. Urology. 2000. PMID: 10925092

4

Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.

Finne P, Auvinen A, Koistinen H, Zhang WM, Määttänen L, Rannikko S, Tammela T, Seppälä M, Hakama M, Stenman UH. Finne P, et al. J Clin Endocrinol Metab. 2000 Aug;85(8):2744-7. doi: 10.1210/jcem.85.8.6725. J Clin Endocrinol Metab. 2000. PMID: 10946875 Clinical Trial.

5

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.

Finne P, Finne R, Auvinen A, Juusela H, Aro J, Määttänen L, Hakama M, Rannikko S, Tammela TL, Stenman U. Finne P, et al. Among authors: finne r. Urology. 2000 Sep 1;56(3):418-22. doi: 10.1016/s0090-4295(00)00672-5. Urology. 2000. PMID: 10962306 Clinical Trial.

6

Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.

Finne P, Zhang WM, Auvinen A, Leinonen J, Määttänen L, Rannikko S, Tammela TL, Stenman UH. Finne P, et al. J Urol. 2000 Dec;164(6):1956-60. J Urol. 2000. PMID: 11061890

7

Prostate-specific antigen and other prostate cancer markers.

Stenman U, Finne P, Zhang W, Leinonen J. Stenman U, et al. Among authors: finne p. Urology. 2000 Dec 20;56(6):893-8. doi: 10.1016/s0090-4295(00)00812-8. Urology. 2000. PMID: 11113726 Review. No abstract available.

8

Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.

Zhang WM, Finne P, Leinonen J, Stenman UH. Zhang WM, et al. Among authors: finne p. Scand J Clin Lab Invest Suppl. 2000;233:51-8. Scand J Clin Lab Invest Suppl. 2000. PMID: 11317942

9

Prostate cancer screening.

Finne P, Auvinen A, Stenman UH. Finne P, et al. Lancet. 2001 Apr 14;357(9263):1201; author reply 1201-2. doi: 10.1016/S0140-6736(00)04340-3. Lancet. 2001. PMID: 11330269 No abstract available.

10

Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination.

Finne P, Auvinen A, Aro J, Juusela H, Määttänen L, Rannikko S, Hakama M, Tammela TL, Stenman UH. Finne P, et al. Eur Urol. 2002 Jun;41(6):619-26; discussion 626-7. doi: 10.1016/s0302-2838(02)00179-3. Eur Urol. 2002. PMID: 12074779 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page